Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07284589 · ClinicalTrials.gov registry record · Phase 2
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
A Phase 2 study of Healthy Volunteers and Healthy (Controls), sponsored by Akiva Mintz.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07284589 is a Phase 2 study of Healthy Volunteers and Healthy (Controls) that is actively recruiting participants, run by Akiva Mintz. The registered enrollment target is 200 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07284589, a Phase 2 study of Healthy Volunteers and Healthy (Controls), is actively recruiting participants, sponsored by Akiva Mintz.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer that binds to a tumor specific protein called somatostatin receptor 2 (SSTR2) and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Conditions Studied
Interventions
- DRUG 68Ga-Dotatate
Study Locations (1)
New Jersey
- Nuclear Imaging Institute - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-11 |
| Est. Completion | 2030-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07284589
The ClinicalTrials.gov registry entry for NCT07284589 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower). The listed sponsor is Akiva Mintz, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which 68Ga-Dotatate is the first listed.
NCT07284589 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07284589 about?
NCT07284589 is a clinical study titled "Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake". The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconst...
What is the current status of trial NCT07284589?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2025-12-11. Estimated completion is 2030-04-30.
What conditions does trial NCT07284589 study?
This clinical trial studies the following conditions: Healthy Volunteers, Healthy (Controls), Neuroendocrine (NE) Tumors.
What interventions are being tested in trial NCT07284589?
The interventions under investigation include: 68Ga-Dotatate (DRUG).
Who is sponsoring clinical trial NCT07284589?
This trial is sponsored by Akiva Mintz, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07284589 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neurobiology of Suicide
RECRUITING · Phase 2
-
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
RECRUITING · Phase 2
-
Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA
ACTIVE NOT RECRUITING · Phase 2
-
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
COMPLETED · Phase 2
-
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
COMPLETED · Phase 2
-
Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.